Last 35 quarters of trend data · Healthcare · Healthcare Providers
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -2.46 | — | — | — | — | 13.98 | 23.57 | — | 7.00 | 18.72 | 19.23 | — | — | — | 33.81 | — | — | 42.68 | 50.11 | 50.09 | 40.77 |
| — | — | — | — | — | -25.3% | +22.6% | — | — | — | -43.1% | — | — | — | -32.5% | — | — | +46.6% | -12.2% | — | — | |
| P/S Ratio | 0.32 | 0.26 | 0.48 | 0.50 | 0.40 | 0.51 | 0.55 | 0.63 | 0.38 | 0.64 | 0.57 | 0.64 | 0.16 | 0.53 | 0.71 | 0.57 | 0.47 | 1.16 | 1.16 | 1.06 | 1.19 |
| — | -49.4% | -12.3% | -19.9% | +5.1% | -20.6% | -4.5% | -2.2% | +131.2% | +21.9% | -19.5% | +13.4% | -65.5% | -54.6% | -38.9% | -46.4% | -60.0% | -33.0% | -23.3% | -52.2% | -33.1% | |
| P/B Ratio | 0.65 | 0.62 | 1.02 | 1.09 | 0.88 | 0.76 | 0.81 | 0.93 | 0.82 | 1.01 | 0.91 | 1.04 | 0.66 | 0.71 | 0.76 | 0.78 | 1.19 | 1.20 | 1.16 | 1.05 | 1.61 |
| — | -17.5% | +26.2% | +17.5% | +7.3% | -24.9% | -11.0% | -10.7% | +24.6% | +42.5% | +20.2% | +33.4% | -44.7% | -41.0% | -34.4% | -25.5% | -26.0% | -27.0% | -41.5% | -56.0% | -81.7% | |
| P/FCF | 12.17 | 3.77 | — | — | 4.25 | 4.59 | 4.41 | — | 4.45 | 4.52 | 2.91 | — | 3.64 | 14.12 | 111.75 | 8.26 | — | 50.26 | 23.50 | — | 22.35 |
| — | -18.0% | — | — | -4.3% | +1.7% | +51.2% | — | +22.2% | -68.0% | -97.4% | — | — | -71.9% | +375.6% | — | — | — | +114.5% | — | +20.8% | |
| EV / EBITDA | 13.39 | — | — | 7.95 | 5.18 | 4.33 | 4.43 | 7.47 | 4.41 | 5.85 | 6.14 | 6.62 | — | — | 6.39 | 7.63 | 9.41 | 8.26 | 8.46 | 8.66 | 9.50 |
| — | — | — | +6.5% | +17.4% | -26.1% | -27.9% | +12.9% | — | — | -3.9% | -13.3% | — | — | -24.5% | -11.9% | -0.8% | -9.5% | -19.9% | -63.3% | -32.1% | |
| EV / EBIT | 15.00 | — | — | 164.20 | — | 12.36 | 13.96 | 31.05 | 8.26 | 14.23 | 14.47 | 24.99 | — | — | 18.52 | 20.96 | 36.09 | 23.38 | 23.60 | 15.34 | 23.50 |
| — | — | — | +428.9% | — | -13.1% | -3.5% | +24.3% | — | — | -21.9% | +19.2% | — | — | -21.5% | +36.6% | +53.6% | +66.6% | +99.7% | -82.5% | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 17.5% | 15.4% | 14.1% | 12.4% | 19.2% | -9.2% | -9.1% | -13.3% | 38.3% | -14.1% | -7.0% | -6.9% | 52.7% | -18.8% | -15.4% | 12.0% | 48.5% | -16.0% | -14.8% | -13.8% | 15.7% |
| — | +266.5% | +254.5% | +193.3% | -49.9% | +34.4% | -30.3% | -92.5% | -27.4% | +25.0% | +54.6% | -157.5% | +8.8% | -17.8% | -3.8% | +186.6% | +208.0% | -32.2% | -172.4% | -178.1% | +0.4% | |
| Operating Margin | 5.7% | -20.9% | -18.6% | 0.8% | 6.4% | 11.1% | 13.4% | 4.0% | 11.4% | 10.6% | 8.7% | 8.5% | -14.7% | -79.0% | 9.3% | 3.5% | 2.0% | 9.5% | 11.1% | 9.8% | 9.8% |
| — | -287.7% | -239.0% | -78.9% | -43.7% | +4.8% | +53.1% | -53.1% | +177.3% | +113.5% | -5.9% | +141.9% | -848.6% | -931.9% | -16.5% | -64.2% | -80.0% | -40.7% | +5.1% | +207.5% | +6.1% | |
| Net Margin | -2.2% | -20.7% | -18.1% | -2.0% | -12.1% | 4.1% | 2.5% | -1.2% | 5.9% | 3.8% | 3.3% | -0.4% | -17.2% | -77.8% | 2.4% | 2.1% | -0.2% | 2.9% | 2.6% | 8.0% | 3.3% |
| — | -607.8% | -829.6% | -57.6% | -307.0% | +6.3% | -24.1% | -245.7% | +134.1% | +104.9% | +36.4% | -117.0% | -8935.1% | -2791.0% | -9.3% | -73.5% | -105.8% | -76.5% | -79.4% | +1067.6% | +117.3% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -4.6% | -11.8% | -9.2% | -1.1% | -6.5% | 1.5% | 0.9% | -0.5% | 3.2% | 1.5% | 1.3% | -0.1% | -15.9% | -23.1% | 0.6% | 0.7% | -0.1% | 0.8% | 0.7% | 2.0% | 1.1% |
| — | -872.1% | -1096.8% | -130.7% | -301.3% | +0.5% | -29.4% | -214.7% | +120.4% | +106.6% | +104.3% | -120.0% | -13139.8% | -3182.3% | -2.6% | -63.6% | -110.6% | -74.9% | -84.6% | +621.2% | +106.2% | |
| ROA | -1.6% | -3.6% | -3.1% | -0.4% | -2.4% | 0.6% | 0.3% | -0.2% | 1.1% | 0.5% | 0.4% | -0.0% | -5.5% | -9.1% | 0.3% | 0.3% | -0.0% | 0.3% | 0.3% | 0.8% | 0.4% |
| — | -742.5% | -1015.2% | -127.2% | -310.5% | +10.2% | -22.6% | -240.7% | +120.4% | +105.6% | +61.7% | -115.8% | -11036.2% | -3061.2% | -1.1% | -62.6% | -111.3% | -73.7% | -84.3% | +737.9% | +111.2% | |
| ROIC | 4.0% | -3.5% | -3.0% | 0.2% | 1.2% | 1.5% | 1.7% | 0.5% | 2.0% | 1.3% | 1.1% | 1.0% | -4.3% | -8.2% | 0.9% | 0.4% | 0.5% | 0.9% | 1.0% | 0.9% | 1.2% |
| — | -343.3% | -279.5% | -68.4% | -40.8% | +10.8% | +58.5% | -52.9% | +147.8% | +116.0% | +15.1% | +130.2% | -1036.5% | -1001.0% | -9.9% | -50.4% | -63.5% | -38.7% | -26.7% | +71.7% | -51.1% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.25 | 1.66 | 1.49 | 1.32 | 1.25 | 1.17 | 1.22 | 1.34 | 1.35 | 1.43 | 1.49 | 1.59 | 1.56 | 1.32 | 1.06 | 1.08 | 1.08 | 1.08 | 1.09 | 1.11 | 1.15 |
| — | +41.9% | +21.8% | -1.1% | -7.6% | -18.0% | -18.1% | -16.2% | -13.7% | +8.0% | +41.2% | +47.4% | +45.0% | +22.8% | -3.4% | -2.6% | -5.9% | -9.8% | +9.3% | +11.4% | -60.1% | |
| Debt / EBITDA | 3.35 | — | — | 17.65 | 12.53 | 10.80 | 10.88 | 17.90 | 11.32 | 14.12 | 15.56 | 16.35 | — | — | 15.06 | 18.18 | 18.04 | 16.02 | 16.88 | 18.31 | 16.20 |
| — | — | — | -1.4% | +10.7% | -23.6% | -30.1% | +9.4% | — | — | +3.3% | -10.1% | — | — | -10.7% | -0.7% | +11.4% | -2.1% | +14.9% | -35.8% | +14.2% | |
| Current Ratio | 1.02 | 1.13 | 1.12 | 0.92 | 1.02 | 1.08 | 1.06 | 1.29 | 1.33 | 1.24 | 1.15 | 1.33 | 1.21 | 1.31 | 1.24 | 1.23 | 1.28 | 1.35 | 1.39 | 1.39 | 1.34 |
| — | +4.2% | +6.3% | -28.4% | -23.2% | -12.6% | -8.2% | -3.0% | +10.3% | -5.3% | -7.2% | +8.0% | -5.8% | -3.5% | -10.7% | -11.1% | -4.3% | -17.5% | +42.5% | +41.3% | +55.8% | |
| Quick Ratio | 0.81 | 0.98 | 0.98 | 0.71 | 0.81 | 0.86 | 0.82 | 1.07 | 1.09 | 1.00 | 0.94 | 1.11 | 1.00 | 1.05 | 0.99 | 0.97 | 1.00 | 1.08 | 1.15 | 1.16 | 1.09 |
| — | +13.7% | +19.2% | -33.5% | -25.4% | -13.7% | -13.3% | -3.9% | +9.0% | -4.9% | -4.7% | +14.1% | -0.6% | -3.6% | -14.2% | -16.2% | -8.4% | -24.7% | +37.3% | +39.3% | +51.7% | |
| Interest Coverage | 0.86 | -5.45 | -5.21 | 0.21 | -3.01 | 2.43 | 2.06 | 1.00 | 3.38 | 2.02 | 1.84 | 1.17 | -7.11 | -14.09 | 1.63 | 1.47 | 1.10 | 1.80 | 1.94 | 2.93 | 2.31 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 35 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying AHCO stock.
AdaptHealth Corp.'s current P/E is -2.5x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
AdaptHealth Corp.'s current operating margin is 5.7%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking AdaptHealth Corp.'s business trajectory between earnings reports.